Advances in Mesothelioma

Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium). The area most commonly affected is the lining of the lungs and chest wall. Less commonly the lining of the abdomen and rarely the sac surrounding the heart, or the sac surrounding the testis may be affected. Signs and symptoms of mesothelioma may include shortness of breath due to fluid around the lung, a swollen abdomen, chest wall pain, cough, feeling tired, and weight loss. These symptoms typically come on slowly.

In the present book, twelve typical literatures about mesothelioma published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on mesothelioma. We hope this book can demonstrate advances in mesothelioma as well as give references to the researchers, students and other related people.

Sample Chapter(s)
preface (95 KB)
Components of the Book:
  • Chapter 1
    Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9‑month interval with details analysis of cytology in early‑stage mesothelioma
  • Chapter 2
    Mesothelioma‑associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c‑Met/PI3K and WNT signaling but do not protect against cisplatin
  • Chapter 3
    Developing sustainable patient and public involvement in mesothelioma research: multi‑method exploration with researchers, patients, carers, and patient organisations
  • Chapter 4
    Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
  • Chapter 5
    Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
  • Chapter 6
    Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
  • Chapter 7
    Do patterns of past asbestos use and production reflect current geographic variations of cancer risk?: mesothelioma in Ontario and British Columbia, Canada
  • Chapter 8
    Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy
  • Chapter 9
    Testicular mesothelioma disguised as hydrocele: a case report
  • Chapter 10
    Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma
  • Chapter 11
    Occludin is overexpressed in tubo‑ovarian high‑grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance
  • Chapter 12
    Alvopem® (pemetrexed) safety assessment in patients with non‑small cell lung cancer or malignant pleural mesothelioma: a post‑marketing surveillance
Readership: Students, academics, teachers and other people attending or interested in Pediatric Mesothelioma.
Alexander Ries
Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria

Afrodita Marcu
School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7YH, UK

Michele Carbone
Thoracic Oncology, University of Hawaii Cancer Center, 701 Ilalo St,Honolulu, HI 96813, USA

and more...
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top